Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 16.7 | 13.3 | 0.0 |
| Revenue growth | 26.0% | | |
| Cost of goods sold | 69.7 | 84.8 | 102.6 |
| Gross profit | -53.0 | -71.5 | -102.6 |
| Gross margin | -316.4% | -538.5% | |
| Sales and marketing | 23.6 | 18.6 | 24.1 |
| Research and development | 159.1 | 90.9 | 50.7 |
| General and administrative | 83.0 | 60.1 | 61.2 |
| EBIT | -318.8 | -241.1 | -237.1 |
| EBIT margin | -1903.8% | -1814.9% | |
| Pre-tax income | -361.7 | -262.2 | -236.8 |
| Income taxes | 0.1 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% |
| Net income | -361.8 | -262.2 | 0.0 |
| Net margin | -2160.8% | -1973.8% | |
| |
| Diluted EPS | ($4.87) | ($21.46) | $0.00 |
| Shares outstanding (diluted) | 74.3 | 12.2 | 10,791.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|